Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.

In this insightful interview, Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd, discusses the company's recent impressive financial performance, strategies for sustained growth, and the evolving landscape of the Indian pharmaceutical industry.

Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.